Pennant Investors’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-109,800
Closed -$730K 19
2024
Q2
$730K Hold
109,800
0.19% 18
2024
Q1
$1.12M Hold
109,800
0.28% 13
2023
Q4
$1.24M Buy
+109,800
New +$1.24M 0.27% 10